SB-120 shows promising efficacy and excellent safety in clinical trials for advanced breast cancer. Scutellaria barbata selectively targets cancer cell mitochondria and is distinguished by its ability to induce not only inhibition of OXPHOS but also of glycolysis.
Details
More Information
| Ingredients |
|
|---|---|
| Directions | Suggested Use: 2-3 tablets 2-3 times daily. |
| Enable Trials | No |
| Trial Period | --Please select an option-- |
| Trial Discount Value | 0 |
| Subscription Information for Customers | ---Please select static block--- |
| By Date | Enable |
| Default Date | 0 |
| By Cycles/Orders | Enable |
| Default Date | 0 |
| Infinite | Enable |
| Allow Discount After Orders | 0 |
| Number of Discounted Orders | 0 |
| Make Trials Optional | No |
| Trial Discount Type | Fixed |
| Allow to Skip Subscription | No |
| Allow to Pause Subscription | No |
| Allow To Pause After Orders | 1 |
| Allow to Cancel Subscription | No |
| Allow To Cancel After Orders | 1 |
| Allow To Update Billing Frequency | No |
| Allow To Update Next Order Date | No |
| Allow To Update Billing Address | No |
| Allow To Update Shipping Address | No |
Reviews
Only registered users can write reviews. Please Sign in or create an account
{{title}}
{{detail}}